Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,860,768 papers from all fields of science
Search
Sign In
Create Free Account
gadoversetamide
Known as:
(N,N-Bis(2-((carboxymethyl)(((2-methoxyethyl)carbamoyl)methyl)amino)ethyl)glycinato(3-))gadolinium
, Gadoversetamida
, gadoversetamide [Chemical/Ingredient]
Expand
A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Contrast Media
Organometallic Compounds
GADOVERSETAMIDE 0.5 mmol in 1 mL INTRAVENOUS INJECTION, SOLUTION [OPTIMARK]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Anwendung von extrazellulären gadoliniumhaltigen MR-Kontrastmitteln und Risiko der Nephrogenen Systemischen Fibrose Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of…
J. Heverhagen
,
G. Krombach
,
E. Gizewski
2014
Corpus ID: 54528742
Die Nephrogene Systemische Fibrose (NSF) ist eine schwerwiegende Erkrankung, welche auch zum Tode führen kann. Ein kausaler…
Expand
2013
2013
Síndrome de hipotensión endocraneana espontánea: características imagenológicas y correlación fisiopatológica
Silvina de Luca
,
A. S. Aguado
,
L. Tisser
,
Maria F Andraca
,
Laura Muscillo
,
E. Eyheremendy
2013
Corpus ID: 71029786
Objective. To report and show the main imaging features ofspontaneous intracranial hypotension syndrome (SIH) andtheir…
Expand
2013
2013
ISMRM Weekday Educational Course 2013 Salt Lake City
M. Knopp
2013
Corpus ID: 49368976
Introduction While X-ray contrast agents lead to an attenuation of the transmitted x-rays; MR agents use a completely different…
Expand
2010
2010
Reference ID: 2881094 OptiMARK Injection is designated chemically as [8, 11-bis(carboxymethyl)-14-[2-[(2 methoxyethyl)amino]-2-oxoethyl]-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato(3…
2010
Corpus ID: 12223426
Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid…
Expand
2008
2008
Simultaneous Renal Angiography and Quantitative Perfusion Measurement from a Single Time Resolved MRA Data Set
V. Gulani
,
K. Wright
,
+4 authors
R. F. Muzic
2008
Corpus ID: 23566347
Introduction Time resolved imaging with stochastic trajectories (TWIST) is a method for contrast-enhanced MR angiography that…
Expand
2007
2007
The pharmacokinetics of intravenously administered gadoversetamide in normal subjects
2007
Corpus ID: 180254662
information is essential and not available with non-contrast enhanced magnetic resonance imaging (MRI). NSF may result in fatal…
Expand
2007
2007
[Table, Gadoversetamide: Gd-DTPA-BMEA].
K. Cheng
2007
Corpus ID: 100088798
2005
2005
Interference of Gadolinium-Containing Contrast-Enhancing Agents With Colorimetric Calcium Laboratory Testing
A. Löwe
,
T. Balzer
,
U. Hirt
Investigative Radiology
2005
Corpus ID: 12068434
Objectives:The purpose of this study was to evaluate the extent to which various commercially available gadolinium-containing…
Expand
1999
1999
A multicenter, randomized, double‐blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in…
D. Rubin
,
T. Desser
,
+10 authors
J. A. Pierro
1999
Corpus ID: 196412169
The purpose of this study was to evaluate the safety and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist…
Expand